Company / Net Income
Astria Therapeutics, Inc. Net Income History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$94.3M
FY2024
5-year range
-$194.9M / -$37.3M
FY2020-FY2024
Trend
-29.3%
vs FY2023
Sector context
#108 of 216
Health Care
What the data says
At -$94M, Astria Therapeutics, Inc.'s net income ranks #108 of 216 in the Health Care sector. Net Income has fluctuated over the past 10 years, ranging from -$195M in FY2021 to -$6M in FY2019.
Based on SEC 10-K filings.
-$94M in FY2024.
Declined from -$52M to -$94M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#108 of 216 in Health CareTop 50% of 216This company -$94.3M Sector average $454.3M
▼
-120.7% below sector average
Key checks
Key Insights
- In FY2024, net income decreased 29.3% year-over-year.
- Ranks #108 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2019.
- Lowest net income in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 5.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$94.3M | -29.3% |
| FY2023 | -$72.9M | -40.6% |
| FY2022 | -$51.8M | +73.4% |
| FY2021 | -$194.9M | -422.6% |
| FY2020 | -$37.3M | -517.8% |
| FY2019 | -$6.0M | +76.7% |
| FY2018 | -$25.9M | +5.5% |
| FY2017 | -$27.4M | +24.1% |
| FY2016 | -$36.1M | -10.5% |
| FY2015 | -$32.6M | -49.1% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026